Synapse Open Synapse
Biology

STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down

STAT News · · 1 min read

Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.

Latest from STAT News